Latest Leverage News

Loyal Metals has validated an extensive historical drilling dataset at Queensland's Highway Reward Mine, revealing significant unmined copper-gold mineralisation and setting the stage for a new exploration phase backed by $5.8 million in funding.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Alcidion Group has expanded its contract with North Cumbria Integrated Care NHS Foundation Trust to integrate MediViewer into its Miya Precision electronic patient record system, enhancing access to scanned and historical documents.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Hazer Group has been granted a pivotal patent in Singapore for its proprietary graphite morphology process, reinforcing its foothold in Southeast Asia's clean energy and advanced manufacturing markets.

SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.

Lendlease has priced a S$400 million perpetual hybrid securities issue at a fixed 3.90% rate, strengthening its capital structure and preparing for upcoming debt maturities. The move supports its ongoing corporate strategy and regional growth ambitions.

Gumtree Australia Markets Limited has partnered with Australian Community Media to integrate automotive content, cross-list marketplace listings, and offer combined advertising solutions to a shared audience of 7.1 million Australians monthly.

Lunnon Metals reports robust high-grade gold assay results from its Lady Herial deposit, reinforcing confidence in its upcoming open pit development plans within the Kambalda Gold & Nickel Project.

Duketon Mining has secured an option to acquire the Boodanoo Gold Project in Western Australia, featuring a significant historic gold soil anomaly that remains untested by drilling. The company plans to advance exploration rapidly over the next year.

INOVIQ Limited has demonstrated that its CAR-NK-exosome therapy kills over 90% of triple-negative breast cancer cells within 10 hours in laboratory tests, validating its potential as a next-generation cancer treatment.

Washington H. Soul Pattinson and Company Limited (SOL) has completed the allotment of shares under its and Brickworks’ share schemes, issuing over 433 million Topco shares to shareholders. This marks a significant milestone in the companies’ corporate restructuring.